These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11064378

  • 21. In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it.
    Kataoka M, Itsubata S, Masaoka Y, Sakuma S, Yamashita S.
    Biol Pharm Bull; 2011; 34(3):401-7. PubMed ID: 21372392
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS, Aboul-Einien MH, Mohamed OH, Farid SF.
    Eur J Pharm Sci; 2008 Oct 02; 35(3):219-25. PubMed ID: 18675344
    [Abstract] [Full Text] [Related]

  • 24. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
    Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, Lehr CM.
    Eur J Pharm Sci; 2012 Feb 14; 45(3):336-43. PubMed ID: 22172603
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
    Chávez M, Bernal S, Valverde A, Gutierrez MJ, Quindós G, Mazuelos EM.
    J Antimicrob Chemother; 1999 Nov 14; 44(5):697-700. PubMed ID: 10552989
    [Abstract] [Full Text] [Related]

  • 29. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.
    Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T.
    J Control Release; 2006 Mar 10; 111(1-2):56-64. PubMed ID: 16410029
    [Abstract] [Full Text] [Related]

  • 30. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V, Petraitiene R, Groll AH, Sein T, Schaufele RL, Lyman CA, Francesconi A, Bacher J, Piscitelli SC, Walsh TJ.
    Antimicrob Agents Chemother; 2001 Feb 10; 45(2):471-9. PubMed ID: 11158743
    [Abstract] [Full Text] [Related]

  • 31. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov 10; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

  • 32. Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
    Marelli UK, Bezençon J, Puig E, Ernst B, Kessler H.
    Chemistry; 2015 May 26; 21(22):8023-7. PubMed ID: 25917866
    [Abstract] [Full Text] [Related]

  • 33. The Effect of a High-Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma.
    Gupta N, Hanley MJ, Venkatakrishnan K, Wang B, Sharma S, Bessudo A, Hui AM, Nemunaitis J.
    J Clin Pharmacol; 2016 Oct 26; 56(10):1288-95. PubMed ID: 26872892
    [Abstract] [Full Text] [Related]

  • 34. Mechanistic investigation of the negative food effect of modified release zolpidem.
    Andreas CJ, Pepin X, Markopoulos C, Vertzoni M, Reppas C, Dressman JB.
    Eur J Pharm Sci; 2017 May 01; 102():284-298. PubMed ID: 28286289
    [Abstract] [Full Text] [Related]

  • 35. Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system.
    Kataoka M, Masaoka Y, Sakuma S, Yamashita S.
    J Pharm Sci; 2006 Sep 01; 95(9):2051-61. PubMed ID: 16850428
    [Abstract] [Full Text] [Related]

  • 36. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
    Cai Y, Xu C, Chen P, Hu J, Hu R, Huang M, Bi H.
    J Pharmacol Toxicol Methods; 2014 Sep 01; 70(2):175-81. PubMed ID: 25034865
    [Abstract] [Full Text] [Related]

  • 37. Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin.
    Kristin F, René H, Boontida M, Buraphacheep JV, Maximilian A, Johanna M, Peter L.
    Eur J Pharm Sci; 2017 Apr 01; 101():211-219. PubMed ID: 28179133
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of the interval between feeding and drug administration on oral ampicillin absorption in dogs.
    Küng K, Hauser BR, Wanner M.
    J Small Anim Pract; 1995 Feb 01; 36(2):65-8. PubMed ID: 7723291
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.